3,088
Views
11
CrossRef citations to date
0
Altmetric
Reviews

PROTACs for BRDs proteins in cancer therapy: a review

, , , &
Pages 1694-1703 | Received 07 Dec 2021, Accepted 18 May 2022, Published online: 14 Jun 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Wei Liu, Youyou He, Zhongjie Guo, Miaomiao Wang, Xiaodong Han, Hairui Jia, Jin He, Shanshan Miao & Shengzheng Wang. (2023) Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Essam M. Eliwa, Walid E. Elgammal, Amany Belal, Mohammed A. S. Abourehab, Shimaa M. Abd El-Gilil, Ahmed B. M. Mehany & Gameel A. M. Elhagali. (2023) Cu(II)-Promoted the Chemical Synthesis of New Azines-Based Naphthalene Scaffold as In Vitro Potent Mushroom Tyrosinase Inhibitors and Evaluation of Their Antiproliferative Activity. Polycyclic Aromatic Compounds 43:7, pages 6018-6045.
Read now
Wei Yang, Huining Peng, Yong Huang, Zhiyun Peng & Guangcheng Wang. (2022) Synthesis and antitumor activity of litseaone B analogues as tubulin polymerisation inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 2530-2539.
Read now

Articles from other publishers (8)

Hanqiao Xu, Takashi Kurohara, Nobumichi Ohoka, Genichiro Tsuji, Takao Inoue, Mikihiko Naito & Yosuke Demizu. (2023) Development of versatile solid-phase methods for syntheses of PROTACs with diverse E3 ligands. Bioorganic & Medicinal Chemistry, pages 117293.
Crossref
Kenneth K. W. To, Enming Xing, Ross C. Larue & Pui-Kai Li. (2023) BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications. Molecules 28:7, pages 3043.
Crossref
Jaeyoung Moon, Ichiwa Kitty, Kusuma Renata, Sisi Qin, Fei Zhao & Wootae Kim. (2023) DNA Damage and Its Role in Cancer Therapeutics. International Journal of Molecular Sciences 24:5, pages 4741.
Crossref
Ellen K. Crummy, Elizabeth A. Caine, Dareen Mikheil, Cesear Corona, Kristin M. Riching, Chris Hosfield & Marjeta Urh. 2023. Targeted Protein Degradation. Targeted Protein Degradation 81 113 .
Eros Di Giorgio, Roberta Benetti, Emanuela Kerschbamer, Luigi Xodo & Claudio Brancolini. 2023. 97 148 .
Abdelrahman K. A. A. Salama, Marija V. Trkulja, Emilio Casanova & Iris Z. Uras. (2022) Targeted Protein Degradation: Clinical Advances in the Field of Oncology. International Journal of Molecular Sciences 23:23, pages 15440.
Crossref
Irene Preet Bhela, Alice Ranza, Federica Carolina Balestrero, Marta Serafini, Silvio Aprile, Rita Maria Concetta Di Martino, Fabrizio Condorelli & Tracey Pirali. (2022) A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs. Journal of Medicinal Chemistry 65:22, pages 15282-15299.
Crossref
Wei Liu, Hairui Jia, Minghao Guan, Minxuan Cui, Zhuxuan Lan, Youyou He, Zhongjie Guo, Ru Jiang, Guoqiang Dong & Shengzheng Wang. (2022) Discovery of novel tubulin inhibitors targeting the colchicine binding site via virtual screening, structural optimization and antitumor evaluation. Bioorganic Chemistry 118, pages 105486.
Crossref